PHS Fellowship Supplemental Form Instructions

G.430 - PHS Fellowship Supplemental Form
The linked image cannot be displayed. The file may have been moved, renamed, or deleted. Verify that the link points to the correct file and location.

The PHS Fellowship Supplemental Form is used only for
fellowship applications.
This form includes fields to upload several attachments including
the Specific Aims, Research Strategy, and Applicant Background
and Goals.
The attachments in this form, together with the rest of your
application, should include sufficient information needed for
evaluation of the project and fellow, independent of any other
documents (e.g., previous application). Be specific and
informative, and avoid redundancies.
View larger image

Quick Links
Introduction
1.

1. Introduction to Application (for Resubmission applications)

Fellowship Applicant Section
1.

2. Applicant's Background and Goals for Fellowship Training

Research Training Plan Section
1.
2.
3.
4.
5.
6.

3. Specific Aims
4. Research Strategy
5. Respective Contributions
6. Selection of Sponsor and Institution
7. Progress Report Publication List (for Renewal applications)
8. Training in the Responsible Conduct of Research

Sponsor(s), Collaborator(s), and Consultant(s) Section
1.
2.

9. Sponsor and Co-Sponsor Statements
10. Letters of Support from Collaborators, Contributors, and Consultants

Institutional Environment and Commitment to Training Section
1.
2.

11. Description of Institutional Environment and Commitment to Training
12. Description of Candidate’s Contribution to Program Goals

Other Research Training Plan Section
Vertebrate Animals
1.

13. Are vertebrate animals euthanized?

General Instructions for NIH and Other PHS Agencies - Forms Version F Series

2.
3.
4.
5.

14. Vertebrate Animals
15. Select Agent Research
16. Resource Sharing Plan
17. Authentication of Key Biological and/or Chemical Resources

Additional Information Section
1.
2.
3.
4.
5.
6.
7.
8.

18. Human Embryonic Stem Cells
19. Alternate Phone Number
20. Degree Sought During Proposed Award
21. Field of Training for Current Proposal
22. Current or Prior Kirschstein-NRSA Support?
23. Applications for Concurrent Support?
24. Citizenship
25. Change of Sponsoring Institution

Budget Section
1.
2.
3.
4.

26. Tuition and Fees
27. Childcare Costs
28. Present Institutional Base Salary
29. Stipends/Salary During First Year of Proposed Fellowship

Appendix
1.

30. Appendix

Who should use the PHS Fellowship Supplemental Form:
Use the PHS Fellowship Supplemental Form only if you are submitting a fellowship application.
Fellowship applicants and sponsors are strongly encouraged to speak with a PHS Program Official for
Institute- or Center (IC)-specific guidance before preparing this application. Refer to the Table of ICspecific Information, Requirements, and Staff Contacts in your FOA. In addition, a list of contacts
specifically for extramural training at the NIH ICs can be found at NIH Training Advisory Committee
Roster. For AHRQ, see Research Training Staff Contacts. You are encouraged to check these websites for
the most current contact information.
It is important that the attachments in this form be developed in collaboration with your sponsor, but they
should be written by you, the fellowship applicant.
Read all the instructions in the FOA before completing this section to ensure that your application meets
all IC-specific criteria.
Applicants must follow all policies and requirements related to formatting, page limits, and
proprietary information. See the following pages for more information:
•
•

Format Attachments
Page Limits

Form Screenshots

G.- 217

•
•

NIH Grants Policy Statement, Section 2.3.11.2: Confidentiality of Information
NIH Grants Policy Statement, Section 2.3.11.2.2: The Freedom of Information Act

Introduction
1. Introduction to Application (for Resubmission applications)
Who must complete the “Introduction to Application” attachment:
An "Introduction" attachment is required only if the type of application is resubmission or if the FOA
specifies that one is needed. An introduction is not allowed for new or renewal applications.
Descriptions of different types of applications are listed here: NIH Types of Applications.
Format:
Follow the page limits for the Introduction in the NIH Table of Page Limits unless otherwise specified
in the FOA.
Attach this information as a PDF file. See NIH's Format Attachments page. Use of hyperlinks and
URLs is not allowed unless specified in the funding opportunity announcement.
Content:
Resubmission applications: See specific instructions on the content of the Introduction on the
NIH's Resubmission Applications page.

Fellowship Applicant Section
2. Applicant’s Background and Goals for Fellowship Training
Who must complete the "Applicant's Background and Goals for Fellowship Training"
attachment:
The “Applicant’s Background and Goals for Fellowship Training” attachment is required.
Format:
Follow the page limits for Applicant’s Background and Goals for Fellowship Training in the NIH Table
of Page Limits unless otherwise specified in the FOA.
Attach this information as a PDF file. See NIH's Format Attachments page. Use of hyperlinks and
URLs is not allowed unless specified in the funding opportunity announcement.
Content:
Organize the Applicant’s Background and Goals for Fellowship Training attachment in the specified
order and use the instructions provided below unless otherwise specified in the FOA. Start each
section with the appropriate heading - Doctoral Dissertation and Research Experience, Training Goals
and Objectives, and Activities Planned Under this Award.

General Instructions for NIH and Other PHS Agencies - Forms Version F Series

A. Doctoral Dissertation and Research Experience
Briefly summarize your past research experience, results, and conclusions, and describe how
that experience relates to the proposed fellowship. In some cases, a proposed fellowship may
build directly on previous research experiences, results, and conclusions. In other situations,
past research experiences may lead a candidate to apply for a fellowship in a new or different
area of research. Do not list academic courses in this section.
Applicants with no research experience: Describe any other scientific experiences.
Advanced graduate students (i.e., those who have or will have completed their comprehensive
examinations by the time of award): Include a narrative of your planned doctoral dissertation
(may be preliminary).
Postdoctoral fellowship applicants: Specify which areas of your proposed research were part
of your predoctoral thesis or dissertation and which, if any, were part of a previous postdoctoral
project.
B. Training Goals and Objectives

The linked image cannot be displayed. The file may have been moved, renamed, or deleted. Verify that the link points to the correct file and location.

•
•

•

Describe your overall training goals for the duration of the fellowship and how the proposed
fellowship will enable the attainment of these goals.
Identify the skills, theories, conceptual approaches, etc., to be learned or enhanced during
the award, including, as applicable, expertise in rigorous research design, experimental
methods, quantitative approaches, and data analysis and interpretation, as applicable.
Discuss how the proposed research will facilitate your transition to the next career stage.

C. Activities Planned Under this Award

The activities planned under this award should be individually tailored and well-integrated with
your research project.

•

•
•

Describe, by year, the activities (research, coursework, professional development, clinical
activities, etc.) you will be involved in during the proposed award. Estimate the percentage
of time to be devoted to each activity. The percentage should total 100 for each year.
Describe the research skills and techniques that you intend to learn during the award period.
Provide a timeline detailing the proposed research training, professional development, and
clinical activities for the duration of the fellowship award. Detailed timelines of research
activities involving animals, human subjects, or clinical trials are requested in other sections
of the fellowship application and should not be included here. The timeline you provide here
should be distinct from the Study Timeline in the PHS Human Subjects and Clinical Trials
Information form.

Research Training Plan Section
A Research Training Plan is required for all types of fellowship awards and is a major part of the
fellowship application. It is important to relate the proposed research to the applicant's scientific
career goals. Explain the relationship between the applicant’s research on the fellowship award and
the sponsor’s ongoing research program.

Form Screenshots

G.- 219

The information in these introductory paragraphs to the Research Training Plan Section applies to all
Research Training Plan Section attachments: Specific Aims, Research Strategy, Respective
Contributions, Selection of Sponsor and Institution, Progress Report Publication List, and Training in
the Responsible Conduct of Research.
For most types of research, the plan should include:
•
•
•
•
•

a specific hypothesis,
a list of the specific aims and objectives that will be used to examine the hypothesis,
a description of the methods/approaches/techniques to be used in each aim,
a discussion of possible problems and how they will be managed, and
alternative approaches that might be tried if the initial approaches do not work.

The Research Training Plan is expected to be tailored to the experience level of the applicant and to
allow him/her to develop the necessary skills for further career advancement. Reviewers will evaluate
the plan accordingly. The plan should be achievable within the requested time period. Pilot or
preliminary studies and routine data gathering are generally not appropriate as the focus of the
Research Training Plan.
Although applicants for fellowship awards are expected to write the Research Training Plan, the
sponsor should review a draft of the plan and discuss it in detail with the applicant. Review by other
knowledgeable colleagues is also helpful. Although it is understood that fellowship applications do
not require the extensive experimental detail usually incorporated into regular research grant
applications, a fundamentally sound Research Training Plan should be provided.

3. Specific Aims
Who must complete the "Specific Aims" attachment:
The “Specific Aims” attachment is required unless otherwise specified in the FOA.
Format:
Follow the page limits for Specific Aims in the NIH Table of Page Limits, unless otherwise specified in
the FOA. A “Specific Aims” attachment that includes graphics will generate a warning by the Agency
upon submission.
Attach this information as a PDF. See NIH's Format Attachments page. Use of hyperlinks and URLs is
not allowed unless specified in the funding opportunity announcement.
Content:
State concisely the goals of the proposed research and summarize the expected outcome(s),
including the impact that the results of the proposed research will have on the research field(s)
involved.
List succinctly the specific objectives of the research proposed (e.g., to test a stated hypothesis,
create a novel design, solve a specific problem, challenge an existing paradigm or clinical practice,
address a critical barrier to progress in the field, or develop new technology).

4. Research Strategy
Who must complete the "Research Strategy" attachment:

The linked image cannot be displayed. The file may have been moved, renamed, or deleted. Verify that the link points to the correct file and location.

General Instructions for NIH and Other PHS Agencies - Forms Version F Series

The “Research Strategy” attachment is required.
Format:
Follow the page limits for the Research Strategy in the NIH Table of Page Limits unless otherwise
specified in the FOA. Although multiple sections of information are required in the Research Strategy
as detailed below, the page limit applies to the entirety of the single Research Strategy attachment.
Attach this information as a PDF file. See NIH's Format Attachments page. Use of hyperlinks and
URLs is not allowed unless specified in the funding opportunity announcement.
Content:
Organize the Research Strategy in the specified order and use the instructions provided below,
unless otherwise specified in the FOA. Start each section with the appropriate section heading –
Significance, Approach, etc. Cite published experimental details in the Research Strategy and provide
the full reference in G.220 - R&R Other Project Information Form, Bibliography and References Cited.
Note for Applications Proposing the Involvement of Human Subjects and/or Clinical Trials:
•

•

•

Use the Research Strategy section to discuss the overall strategy, methodology, and analyses of
your proposed research, but do not duplicate information collected in the PHS Human Subjects
and Clinical Trials Information form.
The PHS Human Subjects and Clinical Trials Information form will capture detailed study
information, including eligibility criteria; inclusion of women, minorities, and children; and
protection and monitoring plans.
You are encouraged to refer to information in the PHS Human Subjects and Clinical Trials
Information form as appropriate in your discussion (e.g., see Question 2.4 Inclusion of Women
and Minorities).

Note for Applicants with Multiple Specific Aims: you may address the Significance and Approach
either for each Specific Aim individually or for all of the Specific Aims collectively.
1. Significance
•
•
•
•

Explain the importance of the problem or critical barrier to progress that the proposed
project addresses.
Describe the strengths and weaknesses in the rigor of the prior research (both published
and unpublished) that serves as the key support for the proposed project.
Explain how the proposed project will improve scientific knowledge, technical capability,
and/or clinical practice in one or more broad fields.
Describe how the concepts, methods, technologies, treatments, services, or preventative
interventions that drive this field will be changed if the proposed aims are achieved.

2. Approach
•

Describe the overall strategy, methodology, and analyses to be used to accomplish the
specific aims of the project. Describe plans to address weaknesses in the rigor of the prior
research that serves as the key support for the proposed project. Describe the experimental
design and methods proposed and how they will achieve robust and unbiased results.
Unless addressed separately in the Resource Sharing Plan attachment, include how the data
will be collected, analyzed, and interpreted, as well as any resource sharing plans, as

Form Screenshots

G.- 221

•

•
•
•

•

•

•

appropriate. Resources and tools for rigorous experimental design can be found at the
Enhancing Reproducibility through Rigor and Transparency website.
For trials that randomize groups or deliver interventions to groups, describe how your
methods for analysis and sample size are appropriate for your plans for participant
assignment and intervention delivery. These methods can include a group- or clusterrandomized trial or an individually randomized group-treatment trial. Additional information
is available at the Research Methods Resources webpage.
Discuss potential problems, alternative strategies, and benchmarks for success anticipated to
achieve the aims.
If the project is in the early stages of development, describe any strategy to establish
feasibility, and address the management of any high risk aspects of the proposed work.
Explain how relevant biological variables, such as sex, are factored into research designs and
analyses for studies in vertebrate animals and humans. For example, strong justification from
the scientific literature, preliminary data, or other relevant considerations, must be provided
for applications proposing to study only one sex. Refer to NIH Guide Notice on Sex as a
Biological Variable in NIH-funded Research for additional information.
Point out any procedures, situations, or materials that may be hazardous to personnel and
the precautions to be exercised. If applicable, a full discussion on the use of select agents
should appear in the Select Agent Research attachment below.
If research on Human Embryonic Stem Cells (hESCs) is proposed, but an approved cell line
from the NIH hESC Registry cannot be chosen, provide a strong justification for why an
appropriate cell line cannot be chosen from the registry at this time.
If you are proposing to gain clinical trial research experience (i.e., you will not be leading an
independent clinical trial), briefly describe your role on the clinical trial.

As applicable, also include the following information as part of the Research Strategy, keeping
within the two sections (Significance and Approach) listed above.
Preliminary Studies for New Applications:

For new applications, include information on preliminary studies (including data collected by
others in the lab), if any. Discuss the applicant's preliminary studies, data, and/or experience
pertinent to this application.

Progress Report for Renewal Applications:

Renewal applications for individual Fellowships are rare. You should consult with your program
official before preparing such an application.

Note that the Progress Report falls within the Research Strategy and is therefore included in the
page limits for the Research Strategy. If you are submitting a renewal application, provide a
Progress Report. Provide the beginning and ending dates for the period covered since the last
competitive review. In the Progress Report, you should:
•
•
•

Summarize the specific aims of the previous project period and the importance of the
findings, and emphasize the progress made toward their achievement.
Explain any significant changes to the specific aims and any new directions, including
changes resulting from significant budget reductions.
Discuss previous participant enrollment (e.g., recruitment, retention, inclusion of women,
minorities, children, etc.) for any studies meeting the NIH Glossary definition for clinical

General Instructions for NIH and Other PHS Agencies - Forms Version F Series

research. Use the Progress Report section to discuss, but do not duplicate information
collected elsewhere in the application.
Do not include a list of publications, manuscripts accepted for publication, patents, or other
printed materials in the Progress Report. That information will be included in the "Progress
Report Publication List" attachment.

5. Respective Contributions
Who must complete the "Respective Contributions" attachment:
The “Respective Contributions” attachment is required.
Format:
Follow the page limits for Respective Contributions in the NIH Table of Page Limits unless otherwise
specified in the FOA.
Attach this information as a PDF file. See NIH's Format Attachments page. Use of hyperlinks and
URLs is not allowed unless specified in the funding opportunity announcement.
Content:
Describe the collaborative process between you and your sponsor/co-sponsor(s) in the development,
review, and editing of this Research Training Plan. Also discuss your respective roles in accomplishing
the proposed research.

6. Selection of Sponsor and Institution
Who must complete the "Selection of Sponsor and Institution" attachment:
The “Selection of Sponsor and Institution” attachment is required.
Format:
Follow the page limits for Selection of Sponsor and Institution in the NIH Table of Page Limits unless
otherwise specified in the FOA.
Attach this information as a PDF file. See NIH's Format Attachments page. Use of hyperlinks and
URLs is not allowed unless specified in the funding opportunity announcement.
Content:
Describe the rationale/justification for the selection of both the sponsor and the institution.
1.
2.

Explain why the sponsor, co-sponsor (if any), and institution were selected to accomplish the
research training goals. If the proposed research training is to take place at a site other than
the applicant organization, provide an explanation here.
Foreign Institution: If you are proposing a research training experience at a foreign
institution, describe how the foreign institution and sponsor offer special opportunities for
training that are not currently available in the United States. Key factors in the selection of a
foreign institution should be described. The need for and level of proficiency in reading,
speaking, and comprehending the foreign language should be addressed.

Form Screenshots

G.- 223

3.

Postdoctoral and Senior Fellowship Applicants requesting training at their Doctorate
or Current Institution: Training is expected to broaden a fellow's perspective. Therefore, if
you are requesting training at either your doctorate institution or any institution where you
have been training for more than a year, you must explain why further training at that
institution would be valuable. Individuals applying for senior fellowships who are requesting
training at the institution at which they are employed should provide a similar explanation.

7. Progress Report Publication List (for Renewal applications)
Who must complete the “Progress Report Publication List” attachment:
A “Progress Report Publication List” is required only if the type of application is renewal.
Descriptions of different types of applications are listed here: NIH Types of Applications.
Format:
Attach this information as a PDF file. See NIH's Format Attachments page. Use of hyperlinks and
URLs is not allowed other than specified in this section and in the funding opportunity
announcement.
Content:
In the rare instance that you are submitting a renewal application, list the titles and complete
references to all appropriate publications, manuscripts accepted for publication, patents, and other
printed materials that have resulted from the project since it was last reviewed competitively.
You are allowed to cite interim research products. Note: Interim research products have specific
rules and citation requirements. See related Frequently Asked Questions on citing interim research
products and claiming them as products of your NIH award.
Provide the NIH Manuscript Submission reference number (e.g., NIHMS97531) or the PubMed
Central (PMC) reference number (e.g., PMCID234567) for the following types of articles:
•
•
•

Articles that fall under the Public Access Policy;
Articles that were authored or co-authored by the fellowship applicant and arose from NIH
support;
Articles that were authored or co-authored by the fellowship applicant and arose from
AHRQ funding provided after February 19, 2016 (see Guide Notice on Policy for Public
Access to AHRQ-Funded Scientific Publications).

If the PMCID is not yet available because the Journal submits articles directly to PMC on behalf of
their authors, indicate “PMC Journal – In Process.” NIH maintains a list of such journals.
Citations that are not covered by the NIH Public Access Policy, but are publicly available in a free,
online format may include URLs or PMCID numbers along with the full reference. Note that copies of
these publications are not accepted as appendix material.

8. Training in the Responsible Conduct of Research
Who must complete the "Training in the Responsible Conduct of Research" attachment:
The “Training in the Responsible Conduct of Research” attachment is required.

General Instructions for NIH and Other PHS Agencies - Forms Version F Series

Format:
Follow the page limits for Training in the Responsible Conduct of Research in the NIH Table of Page
Limits unless otherwise specified in the FOA.
Attach this information as a PDF file. See NIH's Format Attachments page. Use of hyperlinks and
URLs is not allowed unless specified in the funding opportunity announcement.
Content:
The plan must address the five required instructional components outlined in the NIH Policy on
Instruction in the Responsible Conduct of Research (RCR), as more fully described in the NIH Grants
Policy Statement, Section 11.2.3.4: Responsible Conduct of Research:
1.
2.
3.
4.
5.

Format: Describe the required format of instruction (i.e., face-to-face lectures, coursework,
and/or real-time discussion groups). A plan with only on-line instruction is not acceptable.
Subject Matter: Describe the breadth of subject matter (e.g., conflict of interest, authorship,
data management, human subjects and animal use, laboratory safety, research misconduct,
and research ethics).
Faculty Participation: Describe the role of the sponsor/mentor(s) and other faculty
involvement in the instruction.
Duration of Instruction: Describe the total number of contact hours of instruction, taking
into consideration the duration of the program.
Frequency of Instruction: Instruction must occur during each career stage and at least
once every four years. Document any prior instruction during the applicant’s current career
stage, including the inclusive dates instruction was last completed.

Senior fellows may fulfill the requirement for instruction in RCR by participating as lecturers and
discussion leaders.
For more information:
See the NIH Grants Policy Statement, Section 11.2.3.4: Responsible Conduct of Research.

Sponsor(s), Collaborator(s), and Consultant(s) Section
9. Sponsor and Co-Sponsor Statements
Who must complete the “Sponsor and Co-Sponsor Statement” attachment:
The “Sponsor and Co-Sponsor Statement” attachment is required. The sponsor and each co-sponsor
must provide statements as described below.
Format:
Follow the page limits for Sponsor and Co-Sponsor Statements in the NIH Table of Page Limits
unless otherwise specified otherwise in the FOA.
The Sponsor and Co-Sponsor Statements must be appended together and uploaded as a single PDF
file. See NIH's Format Attachments page. Use of hyperlinks and URLs is not allowed unless specified
in the funding opportunity announcement.

Form Screenshots

G.- 225

Content:
Complete these items as comprehensively as possible so that a meaningful evaluation of the training
environment can be made by the reviewers.
Create a heading at the top of the first page titled “Sponsor and Co-Sponsor Statements.” Organize
each statement in the specified order and use the instructions below, unless otherwise specified in
the FOA. Start each section with the appropriate section heading – Research Support Available;
Sponsor’s/Co-Sponsor’s Previous Fellows/Trainees; Training Plan, Environment, Research Facilities;
Number of Fellows/Trainees to be Supervised During the Fellowship; and Applicant’s Qualifications
and Potential for a Research Career.
Each sponsor and co-sponsor statement must address all of the following sections (A-E).
A. Research Support Available

In a table, list all current and pending research and research training support specifically
available to the applicant for this particular training experience. Include funding source,
complete identifying number, title of the research or training program, name of the PD/PI, start
and end dates, and the amount of the award. If the sponsor’s research support will end prior to
the end of the proposed training period, the sponsor should describe a contingency plan for
how the fellow’s research will be supported.
The role of the sponsor/co-sponsor in the Research Training Plan should be described. If one or
more co-sponsors is proposed, this plan should describe the role of each sponsor and how they
will communicate and coordinate their efforts to mentor the applicant effectively.

B. Sponsor's/Co-Sponsor’s Previous Fellows/Trainees

State the total number of predoctoral and postdoctoral individuals previously sponsored. Select
up to five that are representative, and for those five, provide information on their time spent in
the lab, their present employing organizations, and their present position titles or occupations.

C. Training Plan, Environment, Research Facilities

The applicant’s Research Training Plan should be individualized for the applicant, keeping in
mind the candidate’s strengths and any gaps in needed skills. The Research Training Plan
should be designed to enhance both research and clinical training (if applicable).
Describe the Research Training Plan that you have developed specifically for the fellowship
applicant. Be sure to include the following points:
•
•
•
•

Include items such as classes, seminars, opportunities for interaction with other groups
and scientists, and any professional skills development opportunities.
Describe the research environment and available research facilities and equipment.
Indicate the relationship of the proposed research training to the applicant's career
goals.
Describe the skills and techniques that the applicant will learn. Relate these to the
applicant's career goals.

The information contained in the “Training Plan, Environment, Research Facilities” section of the
Sponsor’s and Co-sponsors’ Statements should be coordinated with information provided
under the Description of Institutional Environment and Commitment to Training attachment
below.

General Instructions for NIH and Other PHS Agencies - Forms Version F Series

F30 Applications: The Research Training Plan should provide opportunities to integrate clinical
experiences during the research training component; a plan for a smooth transition to the
clinical training component; and should have the potential to facilitate the applicant’s transition
to a residency or other program appropriate for his/her career goals. Sponsors and co-sponsors
should discuss these clinical aspects of the applicant’s training as well.
F31, F32, F33 Applications: The Research Training Plan should facilitate the applicant's
transition to the next stage of his/her career. Sponsors and co-sponsors should discuss this
aspect of the applicant's training as well.
D. Number of Fellows/Trainees to be Supervised During the Fellowship

Indicate how many pre- and/or post- doctoral fellows/trainees the Sponsor/Co-sponsor is
expected to supervise during the award period. Co-sponsor statements must also include this
information.

E. Applicant's Qualifications and Potential for a Research Career

Describe how the fellowship applicant is suited for this research training opportunity based on
his/her academic record and research experience level. Include information about how the
Research Training Plan, and your own expertise as the sponsor or co-sponsor, will assist in
producing an independent researcher.

Note: If the applicant is proposing to gain experience in a clinical trial as part of his or her
research training, then the sponsor or co-sponsor should include information in the statement to
document leadership of the clinical trial (in addition to the information above). Include the following:
•
•
•
•
•

•

Source of funding;
ClinicalTrials.gov Identifier (e.g., NCT87654321), if applicable;
A description of how your expertise is appropriate to guide the applicant in any proposed
clinical trials research experience; and
A statement/attestation that the sponsor will be responsible for the clinical trial.
The sponsor must have primary responsibility for leading and overseeing the trial and must
describe how he/she will provide this oversight (be careful to not overstate the fellow’s
responsibilities).
Include details on the specific roles/responsibilities of the fellow and sponsor, keeping in
mind that the terms of a fellowship award do not permit the fellow to lead a clinical trial.

10. Letters of Support from Collaborators, Contributors, and Consultants
Note that Letters of Support are not the same as Reference Letters, which are required for some
fellowship award applications. For more information about Reference Letters see the NIH Reference
Letters page.
Format:
Follow the page limits for Letters of Support from Collaborators, Contributors, and Consultants in the
NIH Table of Page Limits unless otherwise specified in the FOA.
Letters of support must be appended together and uploaded as a single PDF file. See NIH's Format
Attachments page. Hyperlinks and URLs are not allowed unless specified in the funding opportunity
announcement.

Form Screenshots

G.- 227

Content:
If any collaborators, consultants, or advisors are expected to contribute to the scientific development
or execution of the fellow’s planned project and research training, attach letters of support from
those individuals here, describing their anticipated role and contributions.

Institutional Environment and Commitment to Training Section
11. Description of Institutional Environment and Commitment to Training
Who must complete the “Description of Institutional Environment and Commitment to
Training” attachment:
The “Description of Institutional Environment and Commitment to Training” attachment is required,
and includes “Educational Information” for F30 and F31 applications.
Format:
Follow the page limits for the Description of Institutional Environment and Commitment to Training
in the NIH Table of Page Limits unless otherwise specified in the FOA.
Attach this information as a PDF file. See NIH's Format Attachments page. Hyperlinks and URLs are
not allowed unless specified in the funding opportunity announcement.
Content:
Document a strong, well-established research program related to the candidate's area of interest.
Describe opportunities for intellectual interactions with other individuals in training and other
investigators, including courses offered, journal clubs, seminars, and presentations. Indicate the
facilities and other resources that will be made available for both career enhancement and the
research proposed in this application. Refer to the resources description in G.220 - R&R Other
Project Information Form, Facilities and Other Resources, and information provided in the Sponsor
and Co-sponsor Statements attachment.
F30 and F31 applications: Educational Information

Describe the institution’s dual-degree (F30) or graduate (F31) program in which the applicant is
enrolled. This description should include the structure of the program, the required milestones
and their usual timing, the number of courses, any teaching commitments, clinical
requirements, qualifying exams, and the average time to degree over the past 10 years.
Describe the progress/status of the applicant in relation to the program’s timeline, and the
frequency and method by which the program formally monitors and evaluates a student’s
progress.

For F30 applications specifically, describe any clinical tutorials during the graduate research
years and any activities to ease transition from the graduate to the clinical years of the dualdegree program. Describe any research-associated activities during the clinical years of the
dual-degree program.

General Instructions for NIH and Other PHS Agencies - Forms Version F Series

Include the name of the individual providing this information at the end of the description. This
information is typically provided by the director of the graduate program or the department
chair.

12. Description of Candidate’s Contribution to Program Goals
Who must complete the "Description of Candidate’s Contribution to Program Goals"
attachment:

The linked image cannot be displayed. The file may have been moved, renamed, or deleted. Verify that the link points to the correct file and location.

Applicants to diversity-related FOAs (e.g., diversity-related F31): The “Description of Candidate’s
Contribution to Program Goals” attachment is required.
All other Fellowship applicants: Skip the “Description of Candidate’s Contribution to Program
Goals” attachment, as it is not required.
Format:
Attach this information as a PDF file. See NIH's Format Attachments page. Hyperlinks and URLs are
not allowed unless specified in the funding opportunity announcement.
Content:
The sponsoring institution must provide a document on institutional letterhead that explains how
the candidate’s participation will further the goals of the fellowship program to promote diversity in
health-related research. The letter should avoid revealing sensitive personally identifiable
information, such as the candidate’s specific racial/ethnic background or type of disability.
For NIH’s Interest in Diversity, see the Notice of NIH's Interest in Diversity.
Signatures:
The “Description of Candidate’s Contribution to Program Goals” attachment must be dated and
signed by an institutional official. In most cases, this will be the dean or the chairman of the
department. The signature must appear over the signer's name and title at the end of the statement.

Other Research Training Plan Section
Vertebrate Animals
Are Vertebrate Animals Used?
This field is pre-populated from the G.220 - R&R Other Project Information Form.
If you have answered “No” for activities involving vertebrate animals and activities involving
vertebrate animals are not planned at any time during the proposed project at any
performance site: Skip Questions 13 and 14 below.
If you have answered “Yes” for activities involving vertebrate animals: Answer Questions 13 and
14 below in consultation with both your Sponsor and AO.

13. Are vertebrate animals euthanized?
An answer is required if you answered “Yes” to “Are Vertebrate Animals Used?” above.

Form Screenshots

G.- 229

Check "Yes" or "No" to indicate whether animals in the project are euthanized.
If “Yes” to euthanasia, is method consistent with AVMA guidelines?
An answer is required if you answered “Yes” to “Are Vertebrate Animals Euthanized?”
Check “Yes” or “No” to indicate whether the method of euthanasia is consistent with the American
Veterinary Medical Association (AVMA) Guidelines for the Euthanasia of Animals.
For more information: See AVMA Guidelines for the Euthanasia of Animals.
If “No” to AVMA guidelines, describe method and provide scientific justification:
If you answered “No” to “Is method consistent with AVMA guidelines?,” you must describe (in 1000
characters or fewer) the method of euthanasia and provide a scientific justification for its use.
If you answered “Yes” to “Is method consistent with AVMA guidelines?” skip this question and
scientific justification.

14. Vertebrate Animals
Who must complete the “Vertebrate Animals” attachment:
Include a “Vertebrate Animals” attachment if you answered “Yes” to the question “Are Vertebrate
Animals Used?” on the G.220 - R&R Other Project Information Form.
Format:
Attach this information as a PDF file. See NIH's Format Attachments page.
Do not use the Vertebrate Animals attachment to circumvent the page limits of the Research
Strategy. Hyperlinks and URLs are not allowed unless specified in the funding opportunity
announcement.
Content:
If live vertebrate animals are involved in the project, address each of the following criteria:
1.

2.
3.

Description of Procedures: Provide a concise description of the proposed procedures to be
used that involve live vertebrate animals in the work outlined in the “Research Strategy”
attachment. The description must include sufficient detail to allow evaluation of the
procedures. Identify the species, strains, ages, sex, and total numbers of animals by species,
to be used in the proposed work. If dogs or cats are proposed provide the source of the
animals.
Justifications: Provide justification that the species are appropriate for the proposed
research. Explain why the research goals cannot be accomplished using an alternative model
(e.g., computational, human, invertebrate, in vitro).
Minimization of Pain and Distress: Describe the interventions including analgesia,
anesthesia, sedation, palliative care, and humane endpoints that will be used to minimize
discomfort, distress, pain, and injury.

Each of the criteria must be addressed. Failure to adequately address the criteria may negatively
affect the application's impact score. In addition to the 3 criteria above, you should also:

General Instructions for NIH and Other PHS Agencies - Forms Version F Series

•
•

Identify all project performance (or collaborating) sites and describe the proposed research
activities with vertebrate animals that will be conducted at those sites.
Explain when and how animals are expected to be used if plans for the use of animals have
not been finalized.

See the following pages for more information:
•
•
•

NIH’s Office of Laboratory Animal Welfare website
NIH's Vertebrate Animals Section Worksheet
NIH Grants Policy Statement, Section 4.1.1.1: Animal Welfare Assurance Requirements (an
applicable Animal Welfare Assurance will be required if the grantee institution does not have one)

15. Select Agent Research
Who must complete the “Select Agent Research” attachment:
Include a “Select Agent Research” attachment if your proposed activities involve the use of select
agents at any time during the proposed project period, either at the applicant organization or at any
performance site.
Format:
Attach this information as a PDF file. See NIH's Format Attachments page. Hyperlinks and URLs are
not allowed unless specified in the funding opportunity announcement.
For more information:
Select agents are hazardous biological agents and toxins that have been identified by HHS or the
U.S. Department of Agriculture (USDA) as having the potential to pose a severe threat to public
health and safety, to animal and plant health, or to animal and plant products. The Centers for
Disease Control and Prevention (CDC) and the Animal APHIS Select Agent Programs jointly maintain
a list of these agents. See the Federal Select Agent Program website.
See also the NIH Grants Policy Statement, Section 4.1.24.1: Public Health Security and Bioterrorism
Preparedness and Response Act (Select Agents).
Content:
Excluded select agents: If the activities proposed in the application involve only the use of a
strain(s) of select agents which has been excluded from the list of select agents and toxins as per 42
CFR 73.3, the select agent requirements do not apply. Use this “Select Agent Research” attachment
to identify the strain(s) of the select agent that will be used and note that it has been excluded from
this list. The CDC maintains a list of exclusions, which is available on the Select Agents and Toxins
Exclusions website.
Applying for a select agent to be excluded: If the strain(s) is not currently excluded from the list of
select agents and toxins but you have applied or intend to apply to HHS for an exclusion from the
list, use this section to indicate the status of your request or your intent to apply for an exclusion and
provide a brief justification for the exclusion.
All applicants proposing to use select agents: Address the following three points for each site at
which select agent research will take place. Although no specific page limitation applies to this
section, be succinct.

Form Screenshots

G.- 231

1. Identify the select agent(s) to be used in the proposed research.
2. Provide the registration status of all entities* where select agent(s) will be used.
•
•

If the performance site(s) is a foreign institution, provide the name(s) of the country or
countries where select agent research will be performed.
*An “entity” is defined in 42 CFR 73.1 as “any government agency (federal, state, or
local), academic institution, corporation, company, partnership, society, association,
firm, sole proprietorship, or other legal entity.”

3. Provide a description of all facilities where the select agent(s) will be used.
•
•
•

Describe the procedures that will be used to monitor possession, use, and transfer of
select agent(s).
Describe plans for appropriate biosafety, biocontainment, and security of the select
agent(s).
Describe the biocontainment resources available at all performance sites.

16. Resource Sharing Plan
Format:
Attach this information as a PDF file. See NIH's Format Attachments page. Hyperlinks and URLs are
not allowed unless specified in the funding opportunity announcement.
Content:
Data Sharing Plan: Investigators seeking $500,000 or more in direct costs (exclusive of consortium
F&A) in any budget period are expected to include a brief 1-paragraph description of how final
research data will be shared, or explain why data-sharing is not possible (for example human subject
concerns, the Small Business Innovation Development Act provisions, etc.). Specific FOAs may require
that all applications include this information regardless of the dollar level. Applicants are encouraged
to read the FOA carefully and discuss their data-sharing plan with their program contact at the time
they negotiate an agreement with the Institute/Center (IC) staff to accept assignment of their
application. For more information, see the NIH Data Sharing Policy or the NIH Grants Policy
Statement, Section 8.2.3.1: Data Sharing Policy.
Sharing Model Organisms: Regardless of the amount requested, all applications where the
development of model organisms is anticipated are expected to include a description of a specific
plan for sharing and distributing unique model organisms or state why such sharing is restricted or
not possible. For more information, see the NIH Grants Policy Statement, Section 8.2.3.2: Sharing
Model Organisms.
Genomic Data Sharing (GDS): Applicants seeking funding for research that generates large-scale
human or non-human genomic data are expected to provide a plan for sharing of these data.
Examples of large-scale genomic data include genome-wide association studies (GWAS), single
nucleotide polymorphisms (SNP) arrays, and genome sequence, transcriptomic, epigenomic, and
gene expression data. Supplemental Information to the NIH GDS provides examples of genomic
research projects that are subject to the Policy. For more information, see the NIH GDS Policy, the
NIH Grants Policy Statement, Section 8.2.3.3: Genomic Data Sharing (GDS) Policy/Policy for GenomeWide Association Studies (GWAS), and the GDS website.

General Instructions for NIH and Other PHS Agencies - Forms Version F Series

Note on GDS: For proposed studies generating human genomic data under the scope of the GDS
Policy, an Institutional Certification may be submitted at the time of application submission, but it is
not required at that time. The Institutional Certification, however, will be requested as Just-in-Time
(JIT) information prior to award. The Institutional Certification, or in some cases, a Provisional
Institutional Certification, must be submitted and accepted before the award can be issued.
For more information:
NIH considers the sharing of unique research resources developed through NIH-sponsored research
an important means to enhance the value and further the advancement of the research. When
resources have been developed with NIH funds and the associated research findings published or
provided to NIH, it is important that they be made readily available for research purposes to
qualified individuals within the scientific community. See NIH Grants Policy Statement, Section 8.2.3:
Sharing Research Resources.

17. Authentication of Key Biological and/or Chemical Resources
Format:
Attach this information as a PDF file. See NIH's Format Attachments page. Hyperlinks and URLs are
not allowed unless specified in the funding opportunity announcement.
Content:

The linked image cannot be displayed. The file may have been moved, renamed, or deleted. Verify that the link points to the correct file and location.

If applicable to the proposed science, briefly describe methods to ensure the identity and validity of
key biological and/or chemical resources used in the proposed studies. A maximum of one page is
suggested.
More information:
Key biological and/or chemical resources are characterized as follows:
•

•
•

Key biological and/or chemical resources may or may not have been generated with NIH funds
and: 1) may differ from laboratory to laboratory or over time; 2) may have qualities and/or
qualifications that could influence the research data; and 3) are integral to the proposed research.
These include, but are not limited to, cell lines, specialty chemicals, antibodies, and other
biologics.
Standard laboratory reagents that are not expected to vary do not need to be included in the
plan. Examples are buffers and other common biologicals or chemicals.
See NIH's page on Rigor and Reproducibility for more information.

Additional Information Section
18. Human Embryonic Stem Cells
Use the following instructions to complete the fields in this section.
For additional guidance, see the NIH Grants Policy Statement, Section 4.1.13: Human Stem Cell
Research.

Form Screenshots

G.- 233

Does the proposed project involve human embryonic stem cells (hESC)?
An answer to this question is required.
If the proposed project involves hESC, check “Yes” and complete the rest of the fields in the Human
Embryonic Stem Cells section.
If the proposed project does not involve hESC, check “No” and skip the rest of fields in the Human
Embryonic Stem Cells section.
Specific stem cell line cannot be referenced at this time. One from the registry will be used.
If you will use hESC but a specific line from the NIH hESC Registry cannot be chosen at the time of
application submission, check this box. Additionally, provide a strong justification (in the Research
Strategy) for why an appropriate cell line cannot be chosen from the registry at this time.
If you cannot specify which cell lines will be used at the time of application submission, specific cell
line information will be required as Just-in-Time information prior to award.
Cell Line(s):
List the 4-digit registration number of the specific cell line(s) from the NIH hESC Registry (e.g. 0123).
Up to 200 lines can be added.

19. Alternate Phone Number
Enter an alternate phone number (e.g., cell phone) for the fellowship applicant. This should be a
different number than the one provided in the PD/PI contact information in the G.200 - SF424 (R&R)
Form.

20. Degree Sought During Proposed Award
Complete the following fields if you will be working toward a degree while receiving fellowship
support.
Degree:
Select the type of degree you will be working toward during the proposed award. If the degree is not
on the drop down menu, please select “OTH: Other.”
If “other,” indicate degree type:
If you selected “OTH: Other” for the “Degree,” indicate the type of degree you will be working toward
during the proposed award.
Expected Completion Date (MM/YYYY):
Enter the expected completion date of the degree sought during the proposed award.

21. Field of Training for Current Proposal
An answer to this field required.
Select a single "Field of Training" code that best describes the proposed area of research training.
This information is used for reporting purposes only and is not used for study section assignments.

General Instructions for NIH and Other PHS Agencies - Forms Version F Series

22. Current or Prior Kirschstein-NRSA Support?
Current or Prior Kirschstein-NRSA Support? Yes/No
An answer to this question is required. Check the appropriate box to indicate whether you currently
have or have had prior Kirschstein-NRSA support.
If yes, identify current and prior Kirschstein-NRSA support below:
Select the appropriate “Level” and “Type” of Kirschstein-NRSA support. “Level” indicates either
predoctoral or postdoctoral level (not the level of experience). “Type” indicates either individual
fellowship or institutional research training grant.
If known, enter the start and end dates (month, day, and year) of the support and the grant number
(e.g., T32 GM123456 or F31 HL345678) of the current and/or prior support.
You may enter up to four separate listings for current and/or prior support.
Note on Kirschstein-NRSA time limits: An individual cannot receive more than five years of
cumulative predoctoral Kirschstein-NRSA support and three years cumulative postdoctoral
Kirschstein-NRSA support (the total of institutional grants and individual fellowships) without a
waiver from the awarding component. The awarding components have different policies on waiving
the statutory limits on support. Therefore, the fellowship applicant must request a waiver from the
probable awarding IC before requesting a period of support that would exceed these limits. Refer to
the Table of IC-specific Information, Requirements, and Staff Contacts in your FOA. The fellow’s
sponsor and AOR must endorse the request. The request must include justification and specify the
amount of additional support for which approval is sought. Individuals seeking additional support
beyond the third year of postdoctoral support are strongly advised to consult with their awarding IC
Program Officer before submitting a waiver request. It is important to read carefully the applicable
FOA that may have an overall approval to exceed these limits (e.g., the F30 programs allow for up to
six years of predoctoral support).
If you receive additional Kirschstein-NRSA support while this application is pending, you must
promptly report such information to the awarding component to which this application has been
assigned.

23. Applications for Concurrent Support?
Applications for Concurrent Support? Yes/No
An answer to this question is required. Check the appropriate box to indicate whether the fellowship
applicant has applied or will be applying for other support that would run concurrently with the
period covered by this application.
If yes, describe in an attached file:
Attach this information as a PDF file. See NIH's Format Attachments page. Hyperlinks and URLs are
not allowed unless specified in the funding opportunity announcement.
If you answered “Yes” to the “Applications for Concurrent Support?” question, you must provide a
description of the concurrent support. Include the type, dates, source(s), and amount in the
attachment.

Form Screenshots

G.- 235

If you receive any support from these other applications while this application is pending, you must
promptly report such information to the awarding component to which this application has been
assigned.

24. Citizenship
Information on Citizenship Requirements for Fellowship Applicants:
Individual Kirschstein-NRSA Fellowship Requirements: To be eligible for a Kirschstein-NRSA
individual fellowship (F30, F31, F32, F33), the fellowship applicant must be a citizen or non-citizen
national of the United States or of its possessions or territories, or must have been lawfully admitted
to the United States for permanent residence by the time the award is issued. Individuals on
temporary student visas are not eligible for NRSA support unless otherwise specified in the FOA.
Non-NRSA Requirements: If you are applying for a non-NRSA fellowship program supported by
the NIH for which citizenship or permanent residency is not required (e.g., Fogarty International
Center programs, F99/K00), you must have a valid visa in your possession that allows you to remain
in the United States (or in a foreign research training setting, if applicable) long enough to be
productive on the proposed fellowship project. It is the responsibility of the sponsoring institution to
determine and document in the application that the individual fellowship applicant’s visa will allow
him or her to remain in the proposed research training setting for the period of time necessary to
complete the proposed fellowship. Information may be requested by the NIH or another PHS Agency
prior to issuance of an award.
All Fellowship Applicants:
Check the applicable boxes for the following questions:
U.S. Citizen: U.S. Citizen or Non-Citizen National? Yes/No
Check “Yes” if the candidate is a U.S. Citizen or Non-Citizen national; otherwise check “No.”
Non-Citizen nationals are people who, although not citizens of the United States, owe permanent
allegiance to the United States. They generally are people born in outlying possessions of the United
States (e.g., American Samoa and Swains Island).
If you answered “Yes,” skip the rest of “Question 31. Citizenship” and you can continue with
“Question 32. Change of Sponsoring Institution.”
If you answered “No,” please continue to fill out the rest of “Question 31. Citizenship” following the
instructions below.
If “No” to U.S. Citizen or Non-Citizen National, please select the most appropriate response from
the options provided:
Non-U.S. Citizen With a Permanent U.S. Resident Visa:
Check this box if the fellowship applicant has been lawfully admitted for permanent residence
(i.e., is in the possession of a current and valid Permanent Resident Card or other legal
verification of such status).
A notarized statement will be required before an award is issued. The statement must show that
a licensed notary has seen the fellowship applicant’s valid Permanent Resident Card (USCIS

General Instructions for NIH and Other PHS Agencies - Forms Version F Series

Form I-551) or other valid verification from the U.S. Immigration and Naturalization Service of
legal admission to the U.S.
Non-U.S. Citizen With a Temporary U.S. Visa:
Check this box if the fellowship applicant currently holds a temporary U.S. visa.
If you are a non-U.S. citizen with a temporary visa applying for an award that requires
permanent residency status, and expect to be granted a permanent resident visa by the start
date of the award, check here:
If the fellowship applicant has applied for permanent residence and expects to hold a
permanent resident visa by the earliest possible start date of the award, please check this box to
indicate that permanent residence status is pending. A notarized statement will be required as a
part of the pre-award process.

25. Change of Sponsoring Institution
Check this box if you are submitting your application with a change of sponsoring institution. If the
box is checked, you must also provide the name of the former sponsoring institution.

Budget Section
26. Tuition and Fees
Who must complete the “Tuition and Fees” section:
All fellowship applicants must complete this “Tuition and Fees” section.
Content:
Indicate whether funds are being requested for tuition and fees by checking the appropriate box
(“None Requested” or “Funds Requested”).
Predoctoral Fellowship Applicants: List, by year, the estimated costs of tuition and fees.
Postdoctoral and Senior Fellowship Applicants: List, by year, the costs associated with specific
course work (or a degree-granting program, if applicable) that supports the research training
experience and that are identified and described in the “Activities Planned Under this Award” section
of the Applicant’s Background and Goals for Fellowship Training attachment.
For more information:
In accordance with the NIH Grants Policy Statement, Section 11.2.9.4: Institutional Allowance, funds
to offset the costs of health insurance are included in the standard Institutional Allowance, and are
not to be requested as part of Tuition and Fees.
Refer to the NIH Research Training and Career Development website for helpful resources and FAQs
about tuition and fees.

Form Screenshots

G.- 237

27. Childcare Costs
Who must complete the “Childcare Costs” section:
All fellowship applicants must complete this “Childcare Costs” section.
Only Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellows may receive
childcare costs.
Content:
Indicate whether funds are being requested for childcare costs by checking the appropriate box
(“None Requested” or “Funds Requested”).
List, by year, the amount of childcare costs requested.
The NRSA childcare costs apply to full-time NIH-NRSA-supported fellowship positions. Each fellow
is eligible to receive $2,500 per budget period for costs for childcare provided by a licensed childcare
provider. Childcare costs are permitted for dependent children living in the eligible fellow’s home
from birth under the age of 13, or children who are disabled and under age 18. Childcare costs do
not apply to elder or non-child dependent care costs.
For more information:
Refer to NOT-OD-21-074 and FAQs about childcare costs.

28. Present Institutional Base Salary
Who must complete the “Institutional Base Salary” section:
Only senior fellowship applicants should complete the “Institutional Base Salary” section.
Amount:
Provide your present base salary. The value must be in U.S. dollars.
Academic Period:
Indicate the period of time on which the salary is determined (e.g., academic year of 9 months, fulltime 12 months, etc.).
Number of Months:
Indicate the number of months per year you receive your base salary. The number may not be more
than 12, but may include a decimal to indicate partial months (e.g., 9.5).

29. Stipends/Salary During First Year of Proposed Fellowship
Who must complete the “Stipends/Salary During First Year of Proposed Fellowship” section:
Only senior fellowship applicants should complete the “Stipends/Salary During First Year of Proposed
Fellowship” section.

General Instructions for NIH and Other PHS Agencies - Forms Version F Series

a. Federal Stipend Requested: Amount and Number of Months
Enter the amount of the stipend being requested for the initial period of support (i.e., the first year of
proposed fellowship) and the number of months requested.
b. Supplementation from Other Sources: Amount, Number of Months, Type, and Source
Enter the anticipated amount and the number of months (during the first year of the proposed
fellowship) for any stipend/salary supplementation. Also enter the type of supplementation expected
(e.g., sabbatical leave, salary, etc.) and the source of such funding.

Appendix
30. Appendix
Refer to the FOA to determine whether there are any special appendix instructions for your
application. See the updated NIH Guide Notice on the Appendix Policy.
Format:
A maximum of 10 PDF attachments is allowed in the Appendix. If more than 10 allowable appendix
attachments are needed, combine the remaining information into attachment #10. Hyperlinks and
URLs are not allowed unless specified in the funding opportunity announcement.
Use filenames for attachments that are descriptive of the content.
A summary sheet listing all of the items included in the Appendix is encouraged but not required.
When including a summary sheet, it should be included in the first appendix attachment.
Content:
The only allowable appendix materials are:
•
•

Blank data collection forms, blank survey forms, and blank questionnaire forms - or
screenshots thereof
Simple lists of interview questions
Note: In your blank forms and lists, do not include items such as: data, data compilations,
lists of variables or acronyms, data analyses, publications, manuals, instructions,
descriptions or drawings/figures/diagrams of data collection methods or
machines/devices.

•
•

Blank informed consent/assent forms
Other items only if they are specified in the FOA as allowable appendix materials

No other items are allowed in the Appendix. Simply relocating disallowed materials to other parts of
the application will result in a noncompliant application.
Some FOAs may have different instructions for the Appendix. Always follow the instructions in your
FOA if they conflict with these instructions.
Note: Applications will be withdrawn and not reviewed if they do not follow the appendix
requirements in these instructions or in your FOA.

Form Screenshots

G.- 239

Information that expands upon or complements information provided in any section of the
application - even if it is not required for the review - is not allowed in the Appendix unless it is listed
in the allowed appendix materials above or in your FOA. For example, do not include material
transfer agreements (MTA) in the Appendix unless otherwise specified in the FOA.
For more information:
•
•

•

The NIH Guide Notice on Reminder: NIH Applications Must Be Complete and Compliant
With NIH Policy and Application Instructions At Time of Submission.
Failure of reviewers to address non-required appendix materials in their reviews is not an
acceptable basis for an appeal of initial peer review. For more information, see the NIH
Grants Policy Statement, Section 2.4.2: Appeals of Initial Scientific Review.
Appendix Policy Frequently Asked Questions